Micro-Sphere partnership to further support the commercial needs of its customers

1 May 2019

Customers will receive comprehensive support particularly at the critical phases of industrial scale-up, technology transfer and process validation.

Switzerland-based CDMO Micro-Sphere has announced its partnership with PTM Consulting, a leading provider of risk management and process optimisation solutions for the life sciences industry.

Micro-Sphere partnership to further support the commercial needs of its customers

The two companies will join forces to offer customers comprehensive support across the entire drug product development and manufacturing cycle, particularly at the critical phases of industrial scale-up, technology transfer and process validation.

The partnership is part of Micro-Sphere’s drive to increase its service offer to support the commercial needs of its customers.

Micro-Sphere’s expertise in the set-up and optimisation of processes for spray-drying, mixing and capsule filling will be complemented by PTM’s knowledge of quality by design (QbD) and risk management principles, tools and statistics.

The collaboration announcement comes at a pivotal time for Micro-Sphere, which recently appointed a new CEO, Michael Grassberger, the company’s former head of business development.

In his new leadership role, he hopes to spearhead the growth of the CDMO’s commercial operations and see Micro-Sphere become the leading service provider for inhalable powder production through spray-drying and capsule filling.

Grassberger said: “The application of PTM methodology to Micro-Sphere’s processes will facilitate successful technology transfers, ensuring customers meet their desired quality target while minimising costs, time and wastage.

“With Micro-Sphere’s reputation already well-established for early-stage clinical supply, we look to make our mark in the commercial arena so we can fully support our customers for the entire drug development and manufacturing cycle. The collaboration with PTM is central to this vision.

“PTM’s risk-based project approach, deep regulatory knowledge and state-of-the-art statistical tools will strengthen our management of complex projects for our customers and supplement the existing skills and expertise on our team.”

The company also recently successfully completed its bi-annual Swissmedic inspection of its facility near Lugano, resulting in the renewal of its GMP approved status.

Read More

Related news

Legacy ramps up preparations for new Russian track and trace sterilisation regulations

Legacy ramps up preparations for new Russian track and trace sterilisation regulations

18 Jul 2019

Company to install new inspection cameras with higher resolution to ensure readability of more complex codes demanded by the Russian mandated crypto coding.

Read more 
Combination technique improves polysaccharide characterization

Combination technique improves polysaccharide characterization

17 Jul 2019

The AF4-MALS-RI method makes possible the accurate determination of molecular weight distribution of polysaccharide macromolecules.

Read more 
Lubrizol integrates personal, home and health care divisions

Lubrizol integrates personal, home and health care divisions

16 Jul 2019

The new brand - Lubrizol Life Sciences - aims to maximize client speed-to-market, providing enhanced solutions.

Read more 
Bosch finds buyers for its packaging machinery business

Bosch finds buyers for its packaging machinery business

16 Jul 2019

CVC Capital Partners to " take the business forward in the years ahead, and to make it even more competitive".

Read more 
New state-of-the-art cleanroom boosts production of anticancer drugs

New state-of-the-art cleanroom boosts production of anticancer drugs

15 Jul 2019

The GMP facility has been specifically designed to deliver the next generation of anticancer blockbuster ADC drugs for patients globally.

Read more 
Colorcon chooses the Netherlands for new starch manufacturing plant

Colorcon chooses the Netherlands for new starch manufacturing plant

12 Jul 2019

The plant will provide a secure second source of supply of Starch 1500, Pregelatinized Maize Starch.

Read more 
GSK opens new continuous manufacturing facilities in Singapore

GSK opens new continuous manufacturing facilities in Singapore

11 Jul 2019

Opening of continuous manufacturing facilities and expansion of production building will boost capabilities to accelerate the supply of new breakthrough medicines to patients globally.

Read more 
Eisai collaborates with University of Dundee on cancer drug discovery

Eisai collaborates with University of Dundee on cancer drug discovery

10 Jul 2019

It is hoped that research into PROTACs will lead to new drug discoveries for proteins present in cancer, which are difficult to treat with conventional small molecule inhibitors.

Read more 
Onyx Scientific makes strategic investment in commercial API licence

Onyx Scientific makes strategic investment in commercial API licence

10 Jul 2019

Investment fills the growing gap in the market for manufacturers that have the niche capabilities to deliver small-scale commercial API projects.

Read more 
I Holland to share the science behind tool maintenance

I Holland to share the science behind tool maintenance

9 Jul 2019

Proper maintenance - rather than replacement - of compression tooling will improve profitability.

Read more